These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 6229812)

  • 21. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
    Nossel HL
    N Engl J Med; 1976 Aug; 295(8):428-32. PubMed ID: 59314
    [No Abstract]   [Full Text] [Related]  

  • 22. The occurrence and clinical relevance of fibrin fragments in blood.
    Gaffney PJ
    Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemostatic mechanisms and malignant tumors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinopeptide release from fibrinogen.
    Nossel HL; Hurlet-Jensen A; Liu CY; Koehn JA; Canfield RE
    Ann N Y Acad Sci; 1983 Jun; 408():269-78. PubMed ID: 6223557
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
    Touho H; Hino A; Suzuki K; Kubo S; Hirakawa K
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fibrinogen B (soluble fibrinogen), its nature and methods of determination].
    Belitser VA
    Lab Delo; 1980; (9):529-32. PubMed ID: 6157920
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathobiochemistry of DIC.
    Gaffney PJ
    Haematologica; 1980 Oct; 65(5):612-25. PubMed ID: 6450719
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombin and plasmin activity in coronary artery disease.
    Small M; Lowe GD; Douglas JT; Hutton I; Lorimer AR; Forbes CD
    Br Heart J; 1988 Sep; 60(3):201-3. PubMed ID: 2972304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization.
    Kanaide H; Uranishi T; Nakamura M
    Am J Hematol; 1982 Nov; 13(3):229-37. PubMed ID: 7180836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition.
    Wallmo L; Karlsson K; Teger-Nilsson AC
    Acta Obstet Gynecol Scand; 1984; 63(7):637-40. PubMed ID: 6516813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.